139 related articles for article (PubMed ID: 26942880)
21. The cap-translation inhibitor 4EGI-1 induces apoptosis in multiple myeloma through Noxa induction.
Descamps G; Gomez-Bougie P; Tamburini J; Green A; Bouscary D; Maïga S; Moreau P; Le Gouill S; Pellat-Deceunynck C; Amiot M
Br J Cancer; 2012 May; 106(10):1660-7. PubMed ID: 22510748
[TBL] [Abstract][Full Text] [Related]
22. Expression of the eukaryotic translation initiation factor 4E (eIF4E) and 4E-BP1 in esophageal cancer.
Salehi Z; Mashayekhi F
Clin Biochem; 2006 Apr; 39(4):404-9. PubMed ID: 16375881
[TBL] [Abstract][Full Text] [Related]
23. 4E-BP1 degradation and eIF4E truncation occur spatially distinctly in the porcine uterine epithelia and are features of noninvasive implantation in the pig.
Wollenhaupt K; Reinke K; Brüssow KP; Kanitz W; Tomek W
Mol Reprod Dev; 2011 Dec; 78(12):895-905. PubMed ID: 21887718
[TBL] [Abstract][Full Text] [Related]
24. Impact of X-linked inhibitor of apoptosis protein on survival of nasopharyngeal carcinoma patients following radiotherapy.
Ren M; Wang Z; Gao G; Gu X; Wu L; Chen L
Tumour Biol; 2016 Sep; 37(9):11825-11833. PubMed ID: 27048285
[TBL] [Abstract][Full Text] [Related]
25. RPPA-based protein profiling reveals eIF4G overexpression and 4E-BP1 serine 65 phosphorylation as molecular events that correspond with a pro-survival phenotype in chronic lymphocytic leukemia.
Shull AY; Noonepalle SK; Awan FT; Liu J; Pei L; Bollag RJ; Salman H; Ding Z; Shi H
Oncotarget; 2015 Jun; 6(16):14632-45. PubMed ID: 25999352
[TBL] [Abstract][Full Text] [Related]
26. Suppression of translation during in vitro maturation of pig oocytes despite enhanced formation of cap-binding protein complex eIF4F and 4E-BP1 hyperphosphorylation.
Ellederova Z; Kovarova H; Melo-Sterza F; Livingstone M; Tomek W; Kubelka M
Mol Reprod Dev; 2006 Jan; 73(1):68-76. PubMed ID: 16211600
[TBL] [Abstract][Full Text] [Related]
27. eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival.
Graff JR; Konicek BW; Lynch RL; Dumstorf CA; Dowless MS; McNulty AM; Parsons SH; Brail LH; Colligan BM; Koop JW; Hurst BM; Deddens JA; Neubauer BL; Stancato LF; Carter HW; Douglass LE; Carter JH
Cancer Res; 2009 May; 69(9):3866-73. PubMed ID: 19383915
[TBL] [Abstract][Full Text] [Related]
28. Perillyl alcohol and genistein differentially regulate PKB/Akt and 4E-BP1 phosphorylation as well as eIF4E/eIF4G interactions in human tumor cells.
Peffley DM; Sharma C; Hentosh P; Buechler RD
Arch Biochem Biophys; 2007 Sep; 465(1):266-73. PubMed ID: 17601486
[TBL] [Abstract][Full Text] [Related]
29. eIF4E-eIF4G complex inhibition synergistically enhances the effect of sorafenib in hepatocellular carcinoma.
Fang C; Xie H; Zhao J; Wang W; Hou H; Zhang B; Zhou D; Geng X
Anticancer Drugs; 2021 Sep; 32(8):822-828. PubMed ID: 33783376
[TBL] [Abstract][Full Text] [Related]
30. Repressor binding to a dorsal regulatory site traps human eIF4E in a high cap-affinity state.
Ptushkina M; von der Haar T; Karim MM; Hughes JM; McCarthy JE
EMBO J; 1999 Jul; 18(14):4068-75. PubMed ID: 10406811
[TBL] [Abstract][Full Text] [Related]
31. Association between LRRK2 and 4E-BP1 protein levels in normal and malignant cells.
Pons B; Armengol G; Livingstone M; López L; Coch L; Sonenberg N; Ramón y Cajal S
Oncol Rep; 2012 Jan; 27(1):225-31. PubMed ID: 21922152
[TBL] [Abstract][Full Text] [Related]
32. Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma.
Demosthenous C; Han JJ; Stenson MJ; Maurer MJ; Wellik LE; Link B; Hege K; Dogan A; Sotomayor E; Witzig T; Gupta M
Oncotarget; 2015 Apr; 6(11):9488-501. PubMed ID: 25839159
[TBL] [Abstract][Full Text] [Related]
33. Tanshinone IIA Facilitates TRAIL Sensitization by Up-regulating DR5 through the ROS-JNK-CHOP Signaling Axis in Human Ovarian Carcinoma Cell Lines.
Chang CC; Kuan CP; Lin JY; Lai JS; Ho TF
Chem Res Toxicol; 2015 Aug; 28(8):1574-83. PubMed ID: 26203587
[TBL] [Abstract][Full Text] [Related]
34. Meal feeding enhances formation of eIF4F in skeletal muscle: role of increased eIF4E availability and eIF4G phosphorylation.
Vary TC; Lynch CJ
Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E631-42. PubMed ID: 16263769
[TBL] [Abstract][Full Text] [Related]
35. Hierarchical phosphorylation of the translation inhibitor 4E-BP1.
Gingras AC; Raught B; Gygi SP; Niedzwiecka A; Miron M; Burley SK; Polakiewicz RD; Wyslouch-Cieszynska A; Aebersold R; Sonenberg N
Genes Dev; 2001 Nov; 15(21):2852-64. PubMed ID: 11691836
[TBL] [Abstract][Full Text] [Related]
36. Nitric oxide mediates NMDA-induced persistent inhibition of protein synthesis through dephosphorylation of eukaryotic initiation factor 4E-binding protein 1 and eukaryotic initiation factor 4G proteolysis.
Petegnief V; Font-Nieves M; Martín ME; Salinas M; Planas AM
Biochem J; 2008 May; 411(3):667-77. PubMed ID: 18215131
[TBL] [Abstract][Full Text] [Related]
37. EIF4E over-expresses and enhances cell proliferation and cell cycle progression in nasopharyngeal carcinoma.
Wu M; Liu Y; Di X; Kang H; Zeng H; Zhao Y; Cai K; Pang T; Wang S; Yao Y; Hu X
Med Oncol; 2013 Mar; 30(1):400. PubMed ID: 23277284
[TBL] [Abstract][Full Text] [Related]
38. Phosphorylation dynamics of eukaryotic initiation factor 4E binding protein 1 (4E-BP1) is discordant with its potential to interact with eukaryotic initiation factor 4E (eIF4E).
Showkat M; Beigh MA; Bhat BB; Batool A; Andrabi KI
Cell Signal; 2014 Oct; 26(10):2117-21. PubMed ID: 24975846
[TBL] [Abstract][Full Text] [Related]
39. eIF4E binding protein 1 expression is associated with clinical survival outcomes in colorectal cancer.
Chao MW; Wang LT; Lai CY; Yang XM; Cheng YW; Lee KH; Pan SL; Teng CM
Oncotarget; 2015 Sep; 6(27):24092-104. PubMed ID: 26204490
[TBL] [Abstract][Full Text] [Related]
40. A novel, soluble compound, C25, sensitizes to TRAIL-induced apoptosis through upregulation of DR5 expression.
James MA; Seibel WL; Kupert E; Hu XX; Potharla VY; Anderson MW
Anticancer Drugs; 2015 Jun; 26(5):518-30. PubMed ID: 25646742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
